Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
New evidence

Ginkgo cut dizziness severity by 0.76 points on an 11-point scale in a meta-analysis — but nearly all the evidence came from dementia patients, leaving the real-world reach unclear.

This is the first systematic review to pull together multiple trials on ginkgo for dizziness in people with brain disorders, so it's a meaningful step forward — but the results come from a narrow patient group and the studies varied widely, so treat the finding as promising, not settled.

A meta-analysis of nine randomized trials found that ginkgo extract reduced dizziness severity by about three-quarters of a point on an 11-point scale and also improved daily functioning in people with central neurological conditions. However, most participants had dementia, and the underlying studies were quite different from one another, so these exact numbers may not apply to everyone with dizziness.

Where this fits in the evidence

This is among the first studies we've indexed on Ginkgo for Reduced Dizziness Severity — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top